NEW YORK, July 4, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
India Biotechnology in India Industry <\/p>\n
http:\/\/www.reportlinker.com\/p0553099\/India-Biotechnology-in-India-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc<\/a> <\/p>\n This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 102 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene International Limited, Dr. Reddy's Laboratories Ltd., Ecron Acunova, Eli Lilly and Company (India) Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Indian Immunologicals Ltd., Jubilant Life Sciences Limited, Krishidhan Seeds Private Limited, Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt. Ltd., Novozymes South Asia Pvt. Ltd., Nuziveedu Seeds Pvt. Ltd., Ocimum Biosolutions Ltd., Panacea Biotec Ltd., Piramal Healthcare Limited, Quintiles India, Rasi Seeds (P) Ltd., Reliance Life Sciences, Serum Institute of India Ltd., Shantha Biotechnics Limited, SIRO Clinpharm, Strand Life Sciences, Veeda Clinical Research Limited, and Vimta Labs Limited. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. <\/p>\n I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definition and Scope of Study I-3 Bio-Pharmaceuticals I-3 Bio-Agriculture I-3 Bio-Industrial I-3 Bioinformatics I-3 Bio-Services I-3 <\/p>\n II. AN INDIAN MARKET REPORT<\/p>\n 1. OUTLOOK II-1 Recession and Foreign Exchange Rate Decelerate Industry Growth II-1 Industry Emerges Strong Following Recession II-2 Brighter Prospects Ahead for the Indian Biotech Industry II-2<\/p>\n 2. INDUSTRY OVERVIEW II-3 SWOT Analysis II-3 Diversity - Key Strength for the Industry II-4 Major Sectors in the Indian Biotechnology Industry II-4 Government Support for Biotech Innovation - A Boost for the Industry II-5 Challenges Ahead II-5 Concerted Efforts are On to Find a Way Out II-6 Major Industry-Specific Advantages of the Indian Biopharma Sector II-6 Competition II-7<\/p>\n Table 1: Leading Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph\/Chart) II-7<\/p>\n Table 2: Leading Domestic Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph\/Chart) II-8 Exports - A Major Market for Indian Biotech Industry II-8<\/p>\n<\/p>\n Read more from the original source: NEW YORK, July 4, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: India Biotechnology in India Industry http:\/\/www.reportlinker.com\/p0553099\/India-Biotechnology-in-India-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc<\/a> This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates and forecasts are provided for the period 2009 through 2017. Continue reading
\nIndia Biotechnology in India Industry<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"